Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic acid vs placebo in pediatric biliary atresia post-hepatoportoenterostomy (China)
CTR20244503Phase 3Terminated
- Sponsor
- Intercept Pharmaceuticals
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of obeticholic acid in biliary atresia, sponsored by Intercept Pharmaceuticals. Started Dec 2024; status: terminated.
02
Drugs
obeticholic acid
03
Conditions
biliary atresia
Beyond the preview
Go deeper on CTR20244503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244503.